An observational study in Focus of Study Pain Knowledge, sponsored by Belmont University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Belmont University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 2,886 studies in Pain with a site in United States — 315 open to participants now, 393 under way, 24 of them phase 3. Pain · United States.
Among the 2,886 studies in Pain with a site in United States, this one is the 208th largest by enrollment of the 299 observational ones that give a count, is one of 132 that started in 2019, is one of 300 observational ones, and was the 2,855th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →315 of the 2,886 studies in Pain with a site in United States are open now. Recruiting first, the newest first:
Ohio State University · Sites in United States
Ages 21–65
Yale University · Sites in United States
Ages 30–75
Vanderbilt University Medical Center · Sites in United States
Ages 18+
Columbia University · Sites in United States
Ages 6–17
Hospital for Special Surgery, New York · Sites in United States
Ages 18–80 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
2,886 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 249 · Phase 2 417 · Phase 3 375 · Phase 4 372
First in 1957; this study’s year is marked. 132 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is below the median of 100 across 1,253 observational studies indexed under Pain.
Median enrollment 66 across the 2,564 interventional studies, 99 across the 299 observational. Of the 2,228 that completed or were terminated, 1,051 (47%) have results posted.
This tab as a report to print or save as PDF → With an account.
671 of 2,886 have an industry lead sponsor. The 10 most frequent:
Belmont University is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Belmont University has 1 study filed under Pain — fewer than ten, so there is no comparison to draw.
172 of the studies in Pain with a site in United States that are under way reach primary completion within a year, 11 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05000281Phase 3Major Extremity Trauma Research ConsortiumEffect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures | 2026-11-30 |
| NCT07226258Phase 3Saol Therapeutics IncPhase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain | 2026-11-30 |
| NCT05964868Phase 3Jessyka LighthallEfficacy of Liposomal Bupivacaine Post Septorhinoplasty | 2026-12 |
| NCT07832552Phase 3Harrow IncA Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic Surgery | 2026-12 |
| NCT07276542Phase 3The Ketamine Research FoundationClinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved. | 2026-12-31 |
Add all 172 to your calendar (.ics) → With an account.
Among the 2,886 studies in Pain with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial was to learn whether a pain science education session could improve physician assistant students' understanding of pain and their beliefs about people with persistent pain.
The main questions were:
Did students' knowledge of how pain works change after the education session? Did students' beliefs about the relationship between pain, physical impairment, and activity change after the session? Were any changes maintained during the remainder of the physician assistant program?
Participants were students enrolled in one physician assistant master's degree program. All students received a four-hour pain science education session and a 30-minute hands-on laboratory session as part of their curriculum. The session explained that pain is affected by biological, psychological, and social factors. It also included case discussions, small-group activities, pain-related screening tools, and demonstrations of selected pain management techniques.
Participants completed questionnaires before the session, immediately afterward, and at three later points during the program. The final questionnaires were completed shortly before graduation. Researchers compared questionnaire scores across these five time points to examine changes in pain knowledge and pain-related beliefs.
This prospective, single-cohort, longitudinal educational intervention study evaluated changes in physician assistant students' pain neuroscience knowledge and pain-related attitudes and beliefs following a multimodal contemporary pain science education session. The study was conducted within a 27-month, master's-level physician assistant program at a single university in the southeastern United States.
The educational session occurred approximately four months after students entered the program. It was delivered during the second semester and consisted of four hours of classroom instruction followed by a 30-minute laboratory component. Classroom instruction incorporated lecture, small-group active learning, discussion, and case-based application. The content presented pain as a multidimensional experience influenced by biological, psychological, social, behavioral, and contextual factors rather than solely by tissue injury or nociception.
Instruction addressed foundational pain neuroscience, pain mechanisms and phenotyping, biopsychosocial contributors to persistent pain, and guideline-informed approaches to pain management. The session also addressed potential unintended consequences of unnecessary diagnostic imaging, medication- or procedure-focused management, premature referral, and language that may increase fear or reinforce beliefs that pain necessarily indicates tissue damage. Students were introduced to selected screening tools used to identify psychosocial factors that may influence pain, function, and recovery.
The laboratory component provided experiential exposure to laterality recognition activities, quantitative sensory testing, and mirror-based techniques. These activities were intended to reinforce concepts discussed during the classroom portion of the session and to demonstrate selected approaches used in the assessment or management of persistent pain.
The study used a repeated-measures design with data collection at five points across the physician assistant curriculum: immediately before the educational session, immediately after the session, approximately four months after the session, at the completion of didactic education approximately 11 months after the session, and shortly before graduation after completion of clinical rotations approximately 23 months after the session.
All students in the cohort received the curricular education. There was no separate control or comparison group, and the intervention was not randomized. Participation in the research involved consenting to the collection and analysis of questionnaire data. Changes in scores over time were examined using repeated-measures statistical methods. Because other coursework and clinical experiences occurred during the follow-up period, the study was designed to evaluate longitudinal associations with the educational session rather than to establish that the session alone caused all observed changes.
The study was approved by the Belmont University Institutional Review Board. Informed consent was obtained from participants before research data collection.
The study population consisted of 40 students enrolled in a single cohort of a 27-month, master's-level physician assistant program at one university in the southeastern United States. Participants had a mean age of 24.9 years; 60% identified as female and 40% as male. Thirty-five participants provided complete data across all five study time points.
Inclusion Criteria - Enrolled in the participating master's-level physician assistant program
Exclusion Criteria
- None
Participants received a 4.5-hour multimodal contemporary pain science education session consisting of four hours of classroom instruction and a 30-minute laboratory. The classroom portion used lecture, small-group activities, discussion, and case-based application to address pain neuroscience, pain mechanisms, biopsychosocial contributors to persistent pain, guideline-informed care, screening tools, nocebo language, and potential harms of unnecessary imaging, medications, procedures, and referrals. The laboratory provided hands-on exposure to laterality recognition, quantitative sensory testing, and mirror-based techniques.
Revised Neurophysiology of Pain Questionnaire (rNPQ)
The 12-item Revised Neurophysiology of Pain Questionnaire was used to assess pain neuroscience knowledge and has a possible total score ranging from 0 (no items answered correctly) to 12 (all items answered correctly). Each correct answer receives 1 point; incorrect or "undecided" responses receive 0 points. Higher scores represent a better outcome, indicating greater knowledge and understanding of pain neurophysiology
Time frame: Over 23 months, from study enrollment to graduation from the academic program
Health Care Provider's Pain and Impairment Relationship Scale (HC-PAIRS)
The 15-item Health Care Providers' Pain and Impairment Relationship Scale (HC-PAIRS) has a possible total score ranging from 15 to 105: Minimum: 15 - strongest disagreement that pain justifies impairment, disability, or activity limitation Maximum: 105 - strongest agreement that pain justifies impairment, disability, or activity limitation Each item is rated on a 7-point Likert scale, from 1 (completely disagree) to 7 (completely agree). Higher scores represent a less favorable outcome, indicating stronger beliefs that persistent pain warrants disability and activity restriction. Therefore, lower scores are generally considered more consistent with contemporary biopsychosocial pain care.
Time frame: Over 23 months, from study enrollment to graduation from the academic program
Plan to share: Yes — The datasets generated and/or analyzed during the current study are available in Mendeley Data.
Supporting information: Study protocol, Statistical analysis plan, Analytic code
Time frame: Published July 14, 2026, and available indefinitely.
Access criteria: Interested individuals may access the IPD at Curfman, Sue; Best, Will (2026), "Contemporary pain science education and physician associate/assistant students: a longitudinal educational intervention study", Mendeley Data, V1, doi: 10.17632/68ghnjyk7h.1
Data sharing details ↗ · data.mendeley.com
Ran from Sep 2019 to primary completion in Aug 2021, 23 months.
Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 23 months is above that.
Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Belmont University